Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Burda

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Virology|July 20, 2001
Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic cladesH A Mbah, S Burda, M K Gorny, et al.
Journal of Virology|October 24, 2000
Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypesP N Nyambi, A Nádas, H A Mbah, et al.
Journal of Virology|August 8, 1998
Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usageD Cecilia, V N KewalRamani, J O'Leary, et al.
Journal of Virology|December 1, 1994
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1M K Gorny, J P Moore, A J Conley, et al.
Immunology Letters|October 16, 2001
Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120S A Jeffs, M K Gorny, C Williams, et al.
AIDS Research and Human Retroviruses|March 10, 1998
A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 cladesM K Gorny, J R Mascola, Z R Israel, et al.
Cancer Reports (Hoboken, N.J.)|March 1, 2023
The significance of upfront autologous stem cell transplantation for high-intermediate/high-risk stage IV diffuse large B-cell lymphomaAleksei K Koviazin, Larisa V Filatova, Ilia S Zyuzgin, et al.
Journal of Virology|January 28, 1998
Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzeesS Zolla-Pazner, M Lubeck, S Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivityM K Gorny, T C VanCott, C Hioe, et al.
The Journal of Infectious Diseases|April 1, 1997
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccinesS Zolla-Pazner, C Alving, R Belshe, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Virology|July 20, 2001
Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic cladesH A Mbah, S Burda, M K Gorny, et al.
Journal of Virology|October 24, 2000
Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypesP N Nyambi, A Nádas, H A Mbah, et al.
Journal of Virology|August 8, 1998
Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usageD Cecilia, V N KewalRamani, J O'Leary, et al.
Journal of Virology|December 1, 1994
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1M K Gorny, J P Moore, A J Conley, et al.
Immunology Letters|October 16, 2001
Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120S A Jeffs, M K Gorny, C Williams, et al.
AIDS Research and Human Retroviruses|March 10, 1998
A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 cladesM K Gorny, J R Mascola, Z R Israel, et al.
Cancer Reports (Hoboken, N.J.)|March 1, 2023
The significance of upfront autologous stem cell transplantation for high-intermediate/high-risk stage IV diffuse large B-cell lymphomaAleksei K Koviazin, Larisa V Filatova, Ilia S Zyuzgin, et al.
Journal of Virology|January 28, 1998
Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzeesS Zolla-Pazner, M Lubeck, S Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivityM K Gorny, T C VanCott, C Hioe, et al.
The Journal of Infectious Diseases|April 1, 1997
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccinesS Zolla-Pazner, C Alving, R Belshe, et al.
Pageof 2